HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA, Industry Diethanolamine Review Could Be Completed In 1999

This article was originally published in The Rose Sheet

Executive Summary

The continuing investigation on the safety of the cosmetics ingredient diethanolamine is expected to be finished sometime next year. FDA and the Cosmetic Toiletry and Fragrance Association will both conduct individual skin penetration studies on DEA. Assays are expected to commence in the near future. The groups have agreed to coordinate efforts by sharing information from the studies.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005826

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel